Ischemic preconditioning protects neurons from damage and maintains the immunoreactivity of kynurenic acid in the gerbil hippocampal CA1 region following transient cerebral ischemia

被引:20
作者
Lee, Jae-Chul [1 ]
Tae, Hyun-Jin [2 ,3 ]
Cho, Geum-Sil [4 ]
Kim, In Hye [1 ]
Ahn, Ji Hyeon [1 ]
Park, Joon Ha [1 ]
Chen, Bai Hui [5 ,6 ]
Cho, Jeong-Hwi [1 ]
Shin, Bich Na [5 ,6 ]
Cho, Jun Hwi [7 ]
Bae, Eun Joo [8 ]
Park, Jinseu [2 ,3 ]
Kim, Young-Myeong [9 ]
Choi, Soo Young [2 ,3 ]
Won, Moo-Ho [1 ]
机构
[1] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 200701, South Korea
[2] Hallym Univ, Dept Biomed Sci, Chunchon 200702, South Korea
[3] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon 200702, South Korea
[4] Korea Univ, Dept Neurosci, Coll Med, Seoul 136705, South Korea
[5] Hallym Univ, Coll Med, Dept Physiol, Chunchon 200702, South Korea
[6] Hallym Univ, Inst Neurodegenerat & Neuroregenerat, Chunchon 200702, South Korea
[7] Kangwon Natl Univ, Sch Med, Dept Emergency Med, Chunchon 200701, South Korea
[8] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Pediat, Coll Med, Chunchon 200701, South Korea
[9] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 200701, South Korea
基金
新加坡国家研究基金会;
关键词
ischemic preconditioning; transient ischemia; CA1 pyramidal neurons; delayed neuronal death; kynurenic acid; RECEPTOR EXPRESSION; AMINO-ACIDS; BLOOD-FLOW; RAT MODEL; BRAIN; PATHWAY; DEATH; TOLERANCE; STROKE; EXCITOTOXICITY;
D O I
10.3892/ijmm.2015.2171
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pyramidal neurons in region I of hippocampus proper (CA1) are particularly vulnerable to excitotoxic processes following transient forebrain ischemia. Kynurenic acid (KYNA) is a small molecule derived from tryptophan when this amino acid is metabolized through the kynurenine pathway. In the present study, we examined the effects of ischemic preconditioning (IPC) on the immunoreactivity and protein levels of KYNA following 5 min of transient forebrain ischemia in gerbils. The animals were randomly assigned to 4 groups (sham-operated group, ischemia-operated group, IPC + sham-operated group and IPC + ischemia-operated group). IPC was induced by subjecting the gerbils to 2 min of ischemia followed by 1 day of recovery. In the ischemia-operated group, we observed a significant loss of pyramidal neurons in the CA1 stratum pyramidale (SP) at 5 days post-ischemia; however, in the IPC + ischemia-operated group, the pyramidal neurons were well protected. KYNA immunoreactivity in the SP of the ischemia-operated group was significantly altered following ischemia-reperfusion and was very low 5 days following ischemia-reperfusion. In the IPC + ischemia-operated group, however, KYNA immunoreactivity was constitutively detected in the SP of the CA1 region after the ischemic insult. We also found that the alteration pattern of the KYNA protein level in the CA1 region following ischemia was generally similar to the immunohistochemical changes observed. In brief, our findings demonstrated that IPC maintained and even increased KYNA immunoreactivity in the SP of the CA1 region following ischemia-reperfusion. The data from the present study thus indicate that the enhancement of KYNA expression by IPC may be necessary for neuronal survival following transient ischemic injury.
引用
收藏
页码:1537 / 1544
页数:8
相关论文
共 49 条
[1]   ISCHEMIC DELAYED NEURONAL DEATH - A MITOCHONDRIAL HYPOTHESIS [J].
ABE, K ;
AOKI, M ;
KAWAGOE, J ;
YOSHIDA, T ;
HATTORI, A ;
KOGURE, K ;
ITOYAMA, Y .
STROKE, 1995, 26 (08) :1478-1489
[2]   Facilitated beam-walking recovery during acute phase by kynurenic acid treatment in a rat model of photochemically induced thrombosis causing focal cerebral ischemia [J].
Abo, Masahiro ;
Yamauchi, Hideki ;
Suzuki, Masahiko ;
Sakuma, Mio ;
Urashima, Mitsuyoshi .
NEUROSIGNALS, 2006, 15 (02) :102-110
[3]   Kynurenine hydroxylase inhibitors reduce ischemic brain damage:: Studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2YL]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia [J].
Cozzi, A ;
Carpenedo, R ;
Moroni, F .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (07) :771-777
[4]   Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis [J].
Dhodda, VK ;
Sailor, KA ;
Bowen, KK ;
Vemuganti, R .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (01) :73-89
[5]   Pathobiology of ischaemic stroke: an integrated view [J].
Dirnagl, U ;
Iadecola, C ;
Moskowitz, MA .
TRENDS IN NEUROSCIENCES, 1999, 22 (09) :391-397
[6]  
Endres M, 2002, ADV EXP MED BIOL, V513, P455
[7]   Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance [J].
Feng, Zhenq ;
Davis, Daniel P. ;
Sasik, Roman ;
Patel, Hemal H. ;
Drummond, John C. ;
Patel, Piyush M. .
BRAIN RESEARCH, 2007, 1177 :103-123
[8]   BLOOD-BRAIN-BARRIER TRANSPORT OF KYNURENINES - IMPLICATIONS FOR BRAIN SYNTHESIS AND METABOLISM [J].
FUKUI, S ;
SCHWARCZ, R ;
RAPOPORT, SI ;
TAKADA, Y ;
SMITH, QR .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (06) :2007-2017
[9]   KYNURENATE INHIBITION OF CELL EXCITATION DECREASES STROKE SIZE AND DEFICITS [J].
GERMANO, IM ;
PITTS, LH ;
MELDRUM, BS ;
BARTKOWSKI, HM ;
SIMON, RP .
ANNALS OF NEUROLOGY, 1987, 22 (06) :730-734
[10]   Cerebral preconditioning and ischaemic tolerance [J].
Gidday, Jeffrey M. .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (06) :437-448